Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Fortification and Vaccine Response in IDA
NCT06027801Unknown
- Sponsor
- University of Oxford
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferrous fumarate in Japanese encephalitis (JE) and typhoid fever (2 arms), sponsored by University of Oxford. Primary endpoints: Immunoglobulin G concentrations against Salmonella Typhi at Day 56, Immunoglobulin A concentrations against Salmonella Typhi at Day 56 and 1 more. Status: unknown.
02
Drugs
ferrous fumarate
03
Conditions
Japanese encephalitis (JE)typhoid fever
Beyond the preview
Go deeper on NCT06027801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06027801.